statistiche ricercatore

Continente	#
EU - Europa	1.024
NA - Nord America	949
AS - Asia	337
SA - Sud America	60
AF - Africa	7
OC - Oceania	3
Continente sconosciuto - Info sul continente non disponibili	1
Totale	2.381

Nazione	#
US - Stati Uniti d'America	937
GB - Regno Unito	487
RU - Federazione Russa	194
CN - Cina	131
IE - Irlanda	111
SG - Singapore	101
BR - Brasile	49
SE - Svezia	46
IT - Italia	45
UA - Ucraina	45
DE - Germania	31
VN - Vietnam	28
HK - Hong Kong	24
FR - Francia	21
KR - Corea	18
FI - Finlandia	16
CZ - Repubblica Ceca	7
BE - Belgio	6
CA - Canada	6
IN - India	6
TR - Turchia	6
PL - Polonia	5
AR - Argentina	4
BD - Bangladesh	4
ES - Italia	4
AT - Austria	3
CI - Costa d'Avorio	3
EC - Ecuador	3
IQ - Iraq	3
AU - Australia	2
LA - Repubblica Popolare Democratica del Laos	2
LK - Sri Lanka	2
ZA - Sudafrica	2
AE - Emirati Arabi Uniti	1
BB - Barbados	1
CO - Colombia	1
CR - Costa Rica	1
EG - Egitto	1
EU - Europa	1
GT - Guatemala	1
GY - Guiana	1
HU - Ungheria	1
ID - Indonesia	1
IR - Iran	1
JO - Giordania	1
JP - Giappone	1
KG - Kirghizistan	1
KZ - Kazakistan	1
LT - Lituania	1
MA - Marocco	1
MX - Messico	1
MY - Malesia	1
NL - Olanda	1
NZ - Nuova Zelanda	1
PA - Panama	1
PK - Pakistan	1
PR - Porto Rico	1
SA - Arabia Saudita	1
SR - Suriname	1
TH - Thailandia	1
TW - Taiwan	1
UY - Uruguay	1
Totale	2.381

Nome	#
How to assess the effectiveness of nasal influenza vaccines? Role and measurement of sIgA in mucosal secretions	516
The purinergic P2×7 receptor is expressed on monocytes in Behçet's disease and is modulated by TNF-α	299
Synthetic cannabinoid ajulemic acid exerts potent antifibrotic effects in experimental models of systemic sclerosis	274
Comparative analysis of influenza A(H3N2) virus hemagglutinin specific IgG subclass and IgA responses in children and adults after influenza vaccination	244
N. meningitidis and TLR polymorphisms: A fascinating immunomodulatory network	228
Neisseria meningitidis infection: Who, when and where?	226
Fighting Neisseria meningitidis: past and current vaccination strategies	201
Sea buckthorn bud extract displays activity against cell-cultured Influenza virus	159
Evaluating influenza vaccines: Progress and perspectives	149
Proficiency tests to evaluate the impact on assay outcomes of harmonized influenza-specific Intracellular Cytokine Staining (ICS) and IFN-ɣ Enzyme-Linked ImmunoSpot (ELISpot) protocols	105
Totale	2.401

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2020/2021	223	0	0	0	0	0	32	23	38	21	48	28	33
2021/2022	179	25	27	16	11	13	1	10	5	22	14	11	24
2022/2023	206	12	26	20	27	20	46	0	18	27	4	4	2
2023/2024	144	5	4	9	5	7	34	67	0	5	1	1	6
2024/2025	325	19	16	45	13	37	27	2	23	28	13	34	68
2025/2026	529	55	103	60	147	160	4	0	0	0	0	0	0
Totale													2.401